Page 2 - Matinas Biopharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Matinas BioPharma to Webcast Conference Call to Discuss First Quarter 2024 Financial Results and Provide a Business Update on May 9, 2024

BEDMINSTER, N.J., May 02, 2024 Matinas BioPharma Holdings, Inc. , a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal platform.

United statesJody cainMatinas biopharmaMatinas biopharma holdings incNational resilience incBiopharma holdingsPrivate securities litigation reform actNational resilience

Lundquist s Dr Ibrahim Leads Breakthrough Oral Fungal Study

Lundquist s Dr Ibrahim Leads Breakthrough Oral Fungal Study
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Ashraf ibrahimMatinas biopharmaLundquist instituteInvestigator ashraf ibrahimAntimicrobial agents

Oral fungal infection treatment shows promise in preclinical trials

Oral fungal infection treatment shows promise in preclinical trials
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Ashraf ibrahimMatinas biopharmaLundquist institute for biomedical innovation atLundquist instituteBiomedical innovationInvestigator ashraf ibrahimAntimicrobial agents

Matinas BioPharma Prices $10 Million Registered Direct Offering

BEDMINSTER, N.J., April 03, 2024 Matinas BioPharma Holdings, Inc. , a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal .

United statesNew yorkJody cainMatinas biopharmaSecurities exchangeMatinas biopharma holdings incCompany annual report on formExchange commissionA gp alliance global partnersBiopharma holdingsAlliance global partnersSecurities actSecurities exchange actPrivate securities litigation reform actAnnual report

Matinas BioPharma (MTNB) Prices 33 33M Share Offering at $0 35/sh

Matinas BioPharma (MTNB) Prices 33 33M Share Offering at $0 35/sh
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

A gp alliance global partnersMatinas biopharmaAlliance global partners